The metabolic syndrome (MetS) is an important tool that identifies populations at increased risk for cardiovascular disease (CVD) and type 2 diabetes, targeting them for preventive measures. The criteria for the identification of the MetS were initially constructed from data in Caucasian populations. Recent research suggests that the current criteria for the MetS may not accurately characterize disease risk in non-Caucasian populations, either over or underestimating the risk in certain ethnic groups. Altering the criteria for each population by making ethnic-specific cutoffs as has been done with waist circumference will help in more accurate characterization. Using different combinations of the MetS criteria for different ethnic groups based CVD risk and factor analysis needs consideration. With better characterizations of patient populations, the ultimate goal would be to make MetS more accurate for predicting CVD risk while retaining the ease of screening afforded by the MetS. The proposed alterations of definition and criteria of the MetS would ensure its continued viability and sustainability.
Introduction: what is the controversy about metabolic syndrome as applied to different ethnicities?
Since a set of metabolic abnormalities was found to cluster together and confer an increased risk of cardiovascular disease (CVD) in humans in 1988 by Reaven, 1 the literature about
insulin resistance and what is now termed the 'metabolic syndrome' (MetS) has rapidly increased. Numerous articles have been written about its prevalence, predictive value for CVD and the appropriate criteria for its diagnosis. However, controversy has arisen about the use of the MetS as a construct. The American Diabetes Association (ADA) and European Association for the Study of Diabetes have questioned the validity of MetS and suggested that more research needs to be conducted to establish its utility. 2 One of the most contentious areas of debate concerns the applicability of the MetS definition to people of different ethnicities. Numerous researchers have noted the inadequacy of the current definitions of MetS in characterizing non-Caucasian populations, [3] [4] [5] [6] and the process of modifying the MetS criteria to improve its utility in these populations has been initiated. The following discussion seeks to examine the rationale for a modification of the MetS criteria for different ethnic populations. We first will briefly review the conceptual basis and practical use of MetS. We then will review the evidence that demonstrates the inaccuracy of MetS in different ethnic groups. Finally, we will review ethnic specific modifications to the definition of MetS and suggest further modifications that may improve the accuracy of MetS criteria in predicting CVD in ethnic subgroups.
Conceptual basis of the metabolic syndrome
The current major definitions of MetS (WHO, National Cholesterol Education Program/Adult Treatment Panel (NCEP/ATP III) and International Diabetes Federation (IDF)) are depicted in Table 1 . For the most part the criteria are uniform; important differences are noted. Three out of five ATP III criteria are required in an individual for the diagnosis of MetS, and these criteria carry equal weight in the diagnosis of MetS. This is not so for the WHO criteria, which require a formal diagnosis of insulin resistance consisting of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or insulin resistance/diabetes in addition to two out of the other four factors for the definition of MetS. The WHO criteria also employ body mass index (BMI) rather than waist circumference as a criterion, the blood pressure cutoff is higher than the ATP III criteria, and microalbuminuria is added as a criterion. The IDF criteria place primacy on a different component of the MetS, requiring central obesity for the diagnosis in conjunction with two out of four other traits. This is likely due to the strong relationship between central obesity and insulin resistance. Based on the new ADA guidelines for impaired IFG, that cutoff for the diagnosis of the MetS has been decreased to 100 mg/dl in the ATP III and IDF definitions. The most recent ATP III statement focuses on the relationship between MetS and CVD, regarding MetS as a multiplex risk factor for CVD and recognizing CVD as the primary clinical outcome of MetS. 7 The idea of a MetS contrasts with the closely related but disparate physiologic phenomenon of insulin resistance, which has been associated in varying degrees with glucose intolerance, hypertriglyceridemia, low-high-density lipoprotein cholesterol (HDL-C) concentrations and hypertension. Initially thought to be the underlying pathophysiologic derangement linking the disparate factors of the MetS, insulin resistance is now felt to be one of multiple physiologic factors associated with the MetS, although perhaps the most important and the factor that most strongly correlates with risk of CVD. 8 The ATP III report considers insulin resistance as one of the three underlying factors for the MetS, the others being obesity and 'independent factors'. 7 Multiple studies seeking to clarify the underlying etiology of the MetS have detailed anywhere from two to four factors independently associated with the MetS [9] [10] [11] These clusters invariably include insulin resistance but also include factors ranging from obesity to hyperglycemia. Recently, an underlying inflammatory process has been linked to the MetS and postulated as an explanation for the association of MetS with CVD. 12 As of now, inflammatory markers have not been incorporated into the MetS criteria. It is unclear whether the relative separation of MetS from the phenomenon of insulin resistance has added or detracted from its value. Perhaps the best conceptualization of the difference between insulin resistance syndrome and the MetS is that the former is a state that leads to an increased likelihood of other physiologic abnormalities, while the latter is a construct that seeks to define those at increased risk for CVD and type 2 diabetes mellitus (T2DM). 8 The MetS should be seen as a screening tool, like the Framingham Risk Score to identify those at risk for CVD or T2DM and focus preventive approaches toward these individuals. In evaluating the usefulness of MetS then, we must evaluate its utility in predicting CVD and T2DM risk in individuals and populations.
Clinical use of the MetS as a predictor of CVD and T2DM
For a set of criteria to serve effectively as a screening tool for a disease process, the disease should be prevalent, the criteria [20] [21] [22] The identification of MetS has also been shown to distinguish those diabetics at high risk for CVD and those at low risk. Alexander et al. 23 found that when T2DM and MetS are both present in a population, the prevalence of CVD is 19%, while patients with T2DM but not MetS have a prevalence of CVD (7.5%) similar to that of a population without T2DM (8.6%). The predictive power of the MetS is not limited to the prediction of CVD; numerous investigators have noted an increased incidence of T2DM in patients diagnosed with the MetS, 22, 24 and there is evidence that MetS is a better predictor of risk of T2DM than CVD. 25 In terms of ameliorating this risk, the Diabetes Prevention Program showed that either metformin or lifestyle reduces risk of progression to T2DM in high-risk subjects, many of whom exhibited the MetS. 26, 27 Other studies have also shown a reduction in the incidence of T2DM in those with the MetS with lifestyle modification. 28 Current ATP III recommendations for the treatment of those with the MetS are to modify risk through weight reduction and lifestyle changes. 29 Despite these qualifications, some have argued that the MetS falls short of the mark as a predictive tool for CVD risk. Although the MetS predicts an increased risk of CVD, there is conflicting evidence that it provides more information than its component parts or that it adds any additional risk to the Framingham Risk Score. Those who have found no evidence for the value of the MetS as a predictive tool for CVD over and above its component parts or existing risk models have questioned its utility and recommend against its use as a construct. 2, 30, 31 Others have noted persistent value for the MetS in the prediction of CVD despite adjustment for conventional risk factors or for the Framingham Risk Score, arguing for its continued use and relevance. [32] [33] [34] Since the criteria selected for MetS confer the cardiovascular risk attributed to the syndrome, the debate over the general utility of MetS has focused upon the suitability of specific criteria for inclusion in the MetS construct and the modification of these criteria. One particular concern relating to the suitability of the MetS criteria for the prediction of CVD is the applicability of these cutoffs to different ethnic populations.
Problem: the metabolic syndrome as a risk assessment tool in ethnic subgroups CVD morbidity and mortality are not equal in different populations, 35 a phenomenon that most likely arises from differences in genetic, socioeconomic and lifestyle factors. Many investigators have shown both native and migrant Asian Indian populations to be at increased risk for CVD when compared to people belonging to other ethnicities. 36, 37 Yet the prevalence of CVD in South Asians increases after migration to developed countries, an increase that has been attributed to the adverse consequences of adopting a 'Westernized' diet and lifestyle. [38] [39] [40] [41] Meanwhile, a shift from rural to increasingly urban lifestyles has contributed to the CVD epidemic in India. 36 For the MetS to be effective as a predictive tool, it must be able to account accurately for the changes in individuals and populations that confer increased CVD risk. Though the ATP III and WHO definitions of the MetS may meet the requirement as a screening tool for CVD, there is concern that they serve as better screening tools for some populations than others. This criticism has been leveled at other risk models such as the Framingham Risk Score with respect to its use in both a Chinese cohort and in other ethnic subgroups within the United States. In both cases, the Framingham Risk Score overestimated risk in these populations and were validated only after modifications were made to adjust for the prevalence of cardiovascular risk factors and CVD mortality in these populations. 42 The converse is also true: improvement in the characterization of CVD risk by alteration of the MetS criteria would ideally be associated with an increased prevalence of the disorder to be of value. For example, in their examination of the ADA and WHO criteria for hyperglycemia for the prediction of CVD, Barzilay et al. 48 noted discrepant results.
The ADA had changed their screening method for diabetes and other hyperglycemic states from IGT to impaired IFG, while the WHO maintained their screening method as IGT.
In individuals defined as IFG by the ATP criteria the prediction of incident cardiovascular events was similar to that of the WHO criteria, but the WHO criteria identified many more individuals as hyperglycemic. Thus the WHO criteria were more sensitive than the ATP criteria in predicting CVD risk in this particular population despite similar relative risks conferred by the two criteria. Generalizing based on the above data, the implication is that the same criteria for the MetS may have different sensitivities and specificities in different patient populations. The nature of the definition is important. Utilizing a uniform definition of the MetS in different populations with resultant under and overestimation of CVD risk may explain the discrepant results noted by various researchers for the utility of the MetS.
In keeping with this hypothesis, current evidence indicates that the MetS has a surprisingly low prevalence in some populations that exhibit high rates of CVD and T2DM. Japanese, Koreans and Mongolians are known to suffer from high prevalence of T2DM and CVD but were found by Shiwaku et al. 49 to exhibit a low incidence of MetS despite exhibiting metabolic abnormalities similar in degree to those seen in the US population. Similar findings were reported by 
Differences in CVD risk for MetS criteria in different ethnic groups
The primary concern with the applicability of the MetS to different ethnic groups is that the risk imparted by the cutoffs for the criteria that comprise the MetS varies according to ethnic subgroup. Most of the research concerning inaccuracy of the MetS criteria has focused upon the inaccuracy of the BMI/waist circumference classification.
There is a well-established link between obesity and insulin resistance, 51 and inclusion of obesity in the MetS criteria arose in part from this association, since insulin resistance has been shown to increase the rate of CVD. 52, 53 Recent research suggests that obesity also results in subclinical inflammation, which also correlates with CVD risk. 54 Since the parameters for the identification of individuals with increased BMI and waist circumference were extrapolated from Caucasian populations, there is concern that for nonCaucasian populations, the BMI and/or waist circumference criteria do not adequately capture cardiovascular risk.
To support this contention, South Asians and Koreans with 'low' or 'normal' BMI are known to exhibit a high incidence of cardiovascular risk factors and CVD. [55] [56] [57] This discrepancy has a physiologic basis; Razak et al. 58 found that for any BMI Asians had a higher incidence of metabolic abnormalities than North American Caucasians, while others have shown that for any given BMI, Chinese, African-Americans and South Asians exhibit more insulin resistance than Caucasians. [59] [60] [61] In addition, Calle et al. 62 noted that an increased BMI in Caucasian men and women conferred an increased risk of mortality compared to an average weight cohort, an effect that was not observed in an African American population. Corroborating these results, Stevens et al.
found that there was no significant association between
Ethnic specific criteria and metabolic syndrome D Banerjee and A Misra BMI and mortality in African American women in contrast to the increased risk of mortality found in Caucasian women with elevated BMI. If the relationship between BMI and CVD risk vary in different ethnic groups while the definition of abnormal BMI remains fixed, the ability of the MetS to characterize CVD risk will suffer. Thus the BMI and waist circumference criteria should be adjusted for certain ethnic groups. [64] [65] [66] [67] In the same way that BMI does not accurately characterize CVD risk in Asian and African American populations, data suggest that the hypertension criteria also do not accurately capture cardiovascular risk across populations due to differences in the way hypertension imparts CVD risk across ethnic subgroups. Hypertension has generally been considered the criterion of the MetS that has the weakest association with insulin resistance, 68 and the strength of its association with CVD risk varies with ethnicity. The Chinese population, for example, has been found to have a low prevalence of hypertension when compared to their North American Caucasian cohort, but the CVD risk associated with increases in blood pressure is proportionally greater in the Chinese. 69 Similarly, Filipino females with a higher prevalence of both hypertension and the MetS than their white Caucasian counterparts had no excess of subclinical atherosclerosis, 70 suggesting that the MetS hypertension criteria inadequately characterize CVD risk in this population. In the UK, multiple researchers have noted higher prevalence rates of hypertension in populations of African ancestry but lower rates of CVD mortality when compared to their hypertensive white and South Asian cohorts. 71, 72 These mismatches between hypertension and CVD risk in ethnic subgroups suggest that the MetS hypertension criteria should be altered by either changing the cutoffs for different populations or weighting the individual criteria based on their risk contribution to CVD in each population. In the extreme case, one could also argue for the omission of hypertension from the MetS criteria in ethnic groups where the relationship between hypertension and CVD risk is poor. A similar argument can be made for the triglyceride (TG) and HDL-C components of the MetS criteria. We know that the ATP III criterion most likely to identify insulin resistance in individuals is the TG/HDL-C ratio 73 and these factors have been shown to capture much of the cardiovascular risk associated with the MetS. Yet Sone et al. 6 noted that in a Japanese population, HDL-C levels were not a significant risk factor for CVD, in contrast to the United Kingdom Prospective Diabetes Study where HDL-C levels were significantly associated with CVD risk in a British Caucasian population. Hispanics are known to exhibit higher TG and lower HDL-C levels than non-Hispanic Caucasians, 74 yet have similar rates of CVD to non-Hispanic Caucasians. 75, 76 Finally, there are indications that blood glucose levels also do not adequately characterize cardiovascular risk in different populations. Ma et al. 77 Similarly, in a cohort of White Caucasian, South Asian and Afro-Caribbean diabetic patients, ethnic origin was found to be an independent risk factor for microvascular and macrovascular complications. 80 More accurate standards are needed to weight the risk for elevated blood glucose levels for T2DM and CVD in different ethnic populations and alter the cutoffs accordingly, as has been done for white Caucasian populations. For example, Lorenzo et al. 81 noted that lowering the fasting blood glucose cutoff for the ATP criteria resulted in a better prediction of T2DM in a North American Caucasian population. Cumulatively, these data suggest that we need receiver operator characteristic curve (ROC) analysis based cutoffs and/or a weighting system for the various MetS criteria in certain ethnic populations to more accurately capture the risk of CVD and T2DM.
Differences in the clustering of metabolic parameters in different ethnic populations
Recently many investigators have used factor analysis to identify the associations between the different components of the MetS, and this tool may provide information that allows a better understanding of the clustering of the MetS components in different ethnic populations. Factor analysis is a model that attempts to explain the correlation between a large set of variables in terms of a smaller set of unobserved variables. 82 In this way researchers can search for underlying associations between these variables. In the case of the MetS, application of factor analysis suggests that the idea of a unifying underlying syndrome is not supported. These studies have invariably found more than one factor and usually 3-4 factors clustering independently. [9] [10] [11] For example, Hanley et al. 9 identified two factors underlying the metabolic abnormalities comprising the MetS using factor analysis. One was termed a 'metabolic' factor, with positive loadings of BMI, waist circumference, fasting and 2-h glucose, and TG and inverse loadings of insulin sensitivity
Ethnic specific criteria and metabolic syndrome D Banerjee and A Misra and HDL-C. The second was termed a 'blood pressure' factor, with positive loadings of systolic and diastolic blood pressure. This corroborates previous studies that have questioned the link between insulin resistance and hypertension. The variable clustering of the different abnormalities in the MetS in different populations suggests varying risk clusters associated with the MetS and is corroborated by observational data. For example, obesity in African-Americans is more commonly associated with hypertension, while obesity related T2DM is more common in Hispanics. 83 In
Mauritius, Malay females were noted to exhibit a relatively high prevalence of hypertension in association with insulin resistance when compared to other ethnic cohorts. 84 Thus there may be combinations of the MetS criteria that are more appropriate for one population than another in predicting CVD risk. The evidence we currently have suggests that not only should the cutoffs and weights of the criteria for the MetS be altered for different ethnic populations, but the combinations of the MetS criteria for each ethnic group should vary as well. Perhaps more weight should be given to those factors that cluster more strongly in a given population (i.e. obesity and hypertension in AfricanAmericans) or to those factors that contribute most to CVD risk in a given population. Since some factors may not carry appreciable risk in certain ethnic subgroups, these could be omitted from the MetS criteria and substituted with others. Further investigations should be performed to determine to what extent these factors aggregate differently in different populations and how these different clusters translate into alterations of CVD risk. Some investigators have also found that the risk of CVD increases with increasing components of the MetS present in an individual. 32, 33 The increase in risk of T2DM and CVD attributable to the increase in the number of components of the MetS present in different ethnic populations should also be determined.
What has been done to modify the criteria for metabolic syndrome? What should be done?
As noted above, most of the research about modifying the criteria for MetS has focused on the BMI/waist circumference classification. There has been general agreement that the ATP III-defined waist circumference criteria should not be used for Asians based on physiological and epidemiological data. 66 What then should the optimal BMI/waist circumference definition be for the MetS in Asians? Investigators in Singapore used ROC curve analysis to identify the waist circumference in Asians that is the best predictor of two other features of the MetS. They found a waist circumference of 80 cm in women and 90 cm in men to be the best predictors of MetS. 4 Enkhmaa and colleagues 56 developed similar parameters in a Korean population and noted a resultant prevalence of the MetS more in line with the population's prevalence of CVD and diabetes. Misra et al. 66, 67 have proposed similar thresholds for Asian Indians. Based on these data, the IDF has proposed new cutoffs for waist circumference in Asians: 80 cm in women and 90 cm in men. 85 These criteria are currently being used in studies determining the prevalence of the MetS in various populations ( Table 2) .
As of now the modification of the other MetS criteria based on ethnicity has only been suggested rather than enforced. Yet further modification seems necessary given the equal weights afforded the different criteria of MetS despite the apparent variation in CVD risk imparted by these criteria in different ethnic subgroups. The idea of modifying the different criteria of the MetS based on ethnicity would complicate risk assessment, and make international comparison of data difficult, though it is an idea supported by our changing conception of the MetS. Some may question whether such efforts are worthwhile given the concern We feel it is premature at this time to dismiss the MetS syndrome as a construct, especially when given the unclear underlying pathophysiology of these CVD risk factors which tend to cluster together differently in different ethnicities. The research that would be conducted to improve the accuracy of the MetS in different ethnic subgroups would necessarily shed light on these associations and advance our understanding and treatment of CVD.
Future directions
Any modification of the MetS criteria should recognize that the ease of use of the MetS is one of its most attractive features and make an attempt to reproduce this practicality in the modified criteria. It is possible to oversimplify the criteria, as noted by Misra et al., 86 who found that using anthropometric data alone in defining MetS led to a loss in prevalence and a poor relationship with insulin resistance. However, the demonstration by Misra et al. 86 
Summary
All risk prediction engines require modification over time or they risk obsolescence (Table 3 ). Although the current definition of the MetS may be accurate for Caucasian populations, recent data suggest that modification of these criteria is necessary for non-Caucasian populations. All of the criticisms made of the MetS in general are also applicable to the MetS in different ethnic populations. Altering the criteria for each population by making ethnic-specific cutoffs as has been done with BMI/waist circumference is one step toward a more accurate characterization. Using different combinations of the MetS criteria for different ethnic groups based on factor analysis and the CVD risk conferred by these combinations should also be considered. With better characterizations of patient populations, the ultimate goal would be to make MetS more accurate for predicting CVD risk while retaining the ease of screening afforded by the MetS. The viability of the MetS, then, is a race against two types of obsolescence. Either the MetS will fall out of favor due to its poor characterization of populations at risk for CVD and be replaced by current risk models, or the MetS will eventually be replaced by newer, better models based on a better understanding of the clustering of CVD risk factors than we have now. It is our hope that MetS will bow out due to the latter rather than the former. Ethnic specific criteria and metabolic syndrome D Banerjee and A Misra
